2m 2m 2m 2m 2m 2m 2m
United Therapeut (UTHR)
NASDAQ
$521.75-$4.91 (-0.93%)
Price as of Jul 15, 2026 4:09 AM EDT- $22.7BMarket Cap
- 79.60%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
United Therapeut (UTHR)
$521.75-$4.91 (-0.93%)
UTHR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $526.66 | ||
Change | -$8.91 (-1.66%) | ||
Open | $535.57 | ||
High | $536.15 | ||
Low | $523.46 | ||
Previous Close | $535.57 | ||
Volume | 370,663 | ||
30-Day Average Volume | 553,317 | ||
1-Week Change | -6.57% | ||
1-Month Change | -3.54% | ||
1-Year Change | 79.60% | ||
3-Year Change | 127.01% | ||
5-Year Change | 186.87% | ||
Fundamentals | |||
Shares Outstanding | 42.4M | ||
Total Assets | $6.7B | ||
Market Cap | $22.7B | ||
Enterprise Value | $21.7B | ||
Period: QTR TTM FY | |||
Revenue | $781.5M | ||
Net Income | $274.9M | ||
Free Cash Flow | $362.5M | ||
EBIT | $318.3M | ||
EBITDA | $340.9M | ||
Net Working Capital | $2.3B | ||
EPS | $5.82 | ||
Enterprise Value/EBITDA | 64 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 4 | ||
P/E | 92 | ||
PEG | -4 | ||
Price/Free Cash Flow | 63 | ||
Price/Operating Cash Flow | 49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue